RXL
ProShares Ultra Health Care
RXL provides 2x leveraged exposure to a cap-weighted index of US health care companies.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
63.8 M
ASSETS UNDER MGMT
95 bp
EXPENSES
Fund Basics
| Fund sponsor | ProShares |
| Category | US |
| Asset class | Equity |
| Website | link... |
| Inception date | Jan 30, 2007 |
| Assets (mns) | $63 |
| Expense ratio | 95 bp |
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | Quarterly |
| Taxation | 1099 |
| Derivatives-based | Yes |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Asset Allocation
Historical Performance
Standardized Performance (as of 04/30/2025)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 1.8% | -5.7% | -0.4% | -0.4% | 9.3% | 10.2% | -- | 13.5% |
| Dividend Yield | 0.3% | 1.3% | 0.9% | 0.7% | 0.5% | 0.5% | -- | 1.2% |
| Total Returns | 2.1% | -4.4% | 0.4% | 0.3% | 9.9% | 10.7% | -- | 14.7% | Ann. Volatility | 38.6% | 28.9% | 25.2% | 29.0% | 30.0% | 34.0% | -- | 34.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.85 | 13% |
| MSCI EAFE | 1.22 | 28% |
| MSCI Emg Mkts | 0.80 | 12% |
Liquidity Measures
| Avg. volume (000) | 13 |
| ADV traded (mns) | $1 |
| Turnover | 0.8% |
| Avg. Bid/Ask (% of price) | 0.22% |
Technical Indicators
| Recent close | $38.68 |
| 30d moving avg. | $41.31 |
| Annualized volatility | 39.5% |
| Relative strength (RSI) | 41 |
| Short interest | 0.1% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Expense Analysis
| Peer Group | Rules-Based US Equity ETFs |
| # of ETFs | 609 |
| Avg. Expense Ratio | 46.6 bp |
| Std. Deviation | 32.9 bp |
| RXL (95 bp) Percentile rank | 93 |
Peer Group Expense Ratio Distribution
Total Cost of Ownership (TCO) Comparison
| Expense (bp) (A) |
Avg. Bid/Ask (bp) (B) |
TCO (bp) (A)+(B) |
|
|---|---|---|---|
| RXL | 95.0 | 22.3 | 117.3 |
| Peer Avg. | 49.0 | 20.1 | 69.1 |
For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .